Ubiquitination in T-Cell Activation and Checkpoint Inhibition: New Avenues for Targeted Cancer Immunotherapy

The advent of T-cell-based immunotherapy has remarkably transformed cancer patient treatment. Despite their success, the currently approved immunotherapeutic protocols still encounter limitations, cause toxicity, and give disparate patient outcomes. Thus, a deeper understanding of the molecular mech...

Descripción completa

Detalles Bibliográficos
Autores principales: Gavali, Shubhangi, Liu, Jianing, Li, Xinyi, Paolino, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509743/
https://www.ncbi.nlm.nih.gov/pubmed/34639141
http://dx.doi.org/10.3390/ijms221910800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509743/
https://www.ncbi.nlm.nih.gov/pubmed/34639141
http://dx.doi.org/10.3390/ijms221910800

Ejemplares similares